A panel of U.S. health advisers narrowly backed the benefits of a closely watched COVID-19 pill from Merck, setting the stage for a likely authorization of the first drug that Americans could take at home to treat the virus.
The closing of a prominent gender-affirming care program for children in Dallas has dismayed parents across Texas who say that options for their children’s care are few and far between — and they don’t know what comes nextfor kids who need similar care.
In October, CMS’ Innovation Center released the strategy refresh for all of its payment models, which included a strong commitment to addressing equity and understanding and closing health disparities.
The hoarding of limited COVID-19 shots by rich countries — creating virtual vaccine deserts in many poorer ones — doesn't just mean risk for the parts of the world seeing shortages; it threatens the entire globe.
The court order said that CMS had no clear authority from Congress to enact the vaccine mandate for providers participating in the two government healthcare programs for the elderly, disabled and poor.
Cases of the omicron variant of the coronavirus popped up in countries on opposite sides of the world Sunday and many governments rushed to close their borders even as scientists cautioned that it's not clear if the new variant is more alarming than other versions of the virus.
State and local governments have struggled to determine who among the many workers who braved the raging coronavirus pandemic before vaccines became available should qualify for so-called hero pay: Should it go to a small pool of essential workers like nurses or be spread around to others, including grocery store workers?
Federal health regulators say an experimental COVID-19 pill from Merck is effective against the virus, but they will seek input from outside experts on risks of birth defects and other potential problems during pregnancy.